人工血球のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Artificial Blood Cells Market Insights, Forecast to 2028

• レポートコード：QY2203B11239 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療装置

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の人工血球の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に人工血球の世界市場のxxx％を占める「動物ヘモグロビン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「心血管疾患」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の人工血球の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの人工血球市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの人工血球市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 人工血球のグローバル主要メーカーには、Dextro-Sang Corporation、BioPure Corporation、Sangart、Northfield Laboratories、Baxter International、Dentritech、FluorO2 Therapeutics、Nuvox Pharma、Alpha Therapeutic Corporation、HemoBioTechなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 人工血球市場は、種類と用途によって区分されます。世界の人工血球市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 動物ヘモグロビン、ヒトヘモグロビン、幹細胞、その他 【用途別セグメント】 心血管疾患、貧血、臓器移植、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 人工血球製品概要 - 種類別市場（動物ヘモグロビン、ヒトヘモグロビン、幹細胞、その他） - 用途別市場（心血管疾患、貧血、臓器移植、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の人工血球販売量予測2017-2028 - 世界の人工血球売上予測2017-2028 - 人工血球の地域別販売量 - 人工血球の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別人工血球販売量 - 主要メーカー別人工血球売上 - 主要メーカー別人工血球価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（動物ヘモグロビン、ヒトヘモグロビン、幹細胞、その他） - 人工血球の種類別販売量 - 人工血球の種類別売上 - 人工血球の種類別価格 ・用途別市場規模（心血管疾患、貧血、臓器移植、その他） - 人工血球の用途別販売量 - 人工血球の用途別売上 - 人工血球の用途別価格 ・北米市場 - 北米の人工血球市場規模（種類別、用途別） - 主要国別の人工血球市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの人工血球市場規模（種類別、用途別） - 主要国別の人工血球市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の人工血球市場規模（種類別、用途別） - 主要国別の人工血球市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の人工血球市場規模（種類別、用途別） - 主要国別の人工血球市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの人工血球市場規模（種類別、用途別） - 主要国別の人工血球市場規模（トルコ、サウジアラビア） ・企業情報 Dextro-Sang Corporation、BioPure Corporation、Sangart、Northfield Laboratories、Baxter International、Dentritech、FluorO2 Therapeutics、Nuvox Pharma、Alpha Therapeutic Corporation、HemoBioTech ・産業チェーン及び販売チャネル分析 - 人工血球の産業チェーン分析 - 人工血球の原材料 - 人工血球の生産プロセス - 人工血球の販売及びマーケティング - 人工血球の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 人工血球の産業動向 - 人工血球のマーケットドライバー - 人工血球の課題 - 人工血球の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Artificial Blood Cells Market
Due to the COVID-19 pandemic, the global Artificial Blood Cells market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Animal Hemoglobin accounting for % of the Artificial Blood Cells global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Cardiovascular Diseases segment is altered to an % CAGR throughout this forecast period.
China Artificial Blood Cells market size is valued at US$ million in 2021, while the US and Europe Artificial Blood Cells are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Artificial Blood Cells landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Artificial Blood Cells include Dextro-Sang Corporation, BioPure Corporation, Sangart, Northfield Laboratories, Baxter International, Dentritech, FluorO2 Therapeutics, Nuvox Pharma and Alpha Therapeutic Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Artificial Blood Cells Scope and Segment
Artificial Blood Cells market is segmented by Source and by Application. Players, stakeholders, and other participants in the global Artificial Blood Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Source and by Application for the period 2017-2028.
Segment by Source
Animal Hemoglobin
Human Hemoglobin
Stem Cell
Others
Segment by Application
Cardiovascular Diseases
Anemia
Organ Transplant
Others
By Company
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Artificial Blood Cells Product Introduction
1.2 Market by Source
1.2.1 Global Artificial Blood Cells Market Size Growth Rate by Source, 2017 VS 2021 VS 2028
1.2.2 Animal Hemoglobin
1.2.3 Human Hemoglobin
1.2.4 Stem Cell
1.2.5 Others
1.3 Market by Application
1.3.1 Global Artificial Blood Cells Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cardiovascular Diseases
1.3.3 Anemia
1.3.4 Organ Transplant
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Artificial Blood Cells Sales Estimates and Forecasts 2017-2028
2.2 Global Artificial Blood Cells Revenue Estimates and Forecasts 2017-2028
2.3 Global Artificial Blood Cells Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Artificial Blood Cells Sales by Region
2.4.1 Global Artificial Blood Cells Sales by Region (2017-2022)
2.4.2 Global Sales Artificial Blood Cells by Region (2023-2028)
2.5 Global Artificial Blood Cells Revenue by Region
2.5.1 Global Artificial Blood Cells Revenue by Region (2017-2022)
2.5.2 Global Artificial Blood Cells Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Artificial Blood Cells Sales by Manufacturers
3.1.1 Global Top Artificial Blood Cells Manufacturers by Sales (2017-2022)
3.1.2 Global Artificial Blood Cells Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Artificial Blood Cells in 2021
3.2 Global Artificial Blood Cells Revenue by Manufacturers
3.2.1 Global Artificial Blood Cells Revenue by Manufacturers (2017-2022)
3.2.2 Global Artificial Blood Cells Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Artificial Blood Cells Revenue in 2021
3.3 Global Artificial Blood Cells Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Artificial Blood Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Artificial Blood Cells Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Source
4.1 Global Artificial Blood Cells Sales by Source
4.1.1 Global Artificial Blood Cells Historical Sales by Source (2017-2022)
4.1.2 Global Artificial Blood Cells Forecasted Sales by Source (2023-2028)
4.1.3 Global Artificial Blood Cells Sales Market Share by Source (2017-2028)
4.2 Global Artificial Blood Cells Revenue by Source
4.2.1 Global Artificial Blood Cells Historical Revenue by Source (2017-2022)
4.2.2 Global Artificial Blood Cells Forecasted Revenue by Source (2023-2028)
4.2.3 Global Artificial Blood Cells Revenue Market Share by Source (2017-2028)
4.3 Global Artificial Blood Cells Price by Source
4.3.1 Global Artificial Blood Cells Price by Source (2017-2022)
4.3.2 Global Artificial Blood Cells Price Forecast by Source (2023-2028)
5 Market Size by Application
5.1 Global Artificial Blood Cells Sales by Application
5.1.1 Global Artificial Blood Cells Historical Sales by Application (2017-2022)
5.1.2 Global Artificial Blood Cells Forecasted Sales by Application (2023-2028)
5.1.3 Global Artificial Blood Cells Sales Market Share by Application (2017-2028)
5.2 Global Artificial Blood Cells Revenue by Application
5.2.1 Global Artificial Blood Cells Historical Revenue by Application (2017-2022)
5.2.2 Global Artificial Blood Cells Forecasted Revenue by Application (2023-2028)
5.2.3 Global Artificial Blood Cells Revenue Market Share by Application (2017-2028)
5.3 Global Artificial Blood Cells Price by Application
5.3.1 Global Artificial Blood Cells Price by Application (2017-2022)
5.3.2 Global Artificial Blood Cells Price Forecast by Application (2023-2028)
6 North America
6.1 North America Artificial Blood Cells Market Size by Source
6.1.1 North America Artificial Blood Cells Sales by Source (2017-2028)
6.1.2 North America Artificial Blood Cells Revenue by Source (2017-2028)
6.2 North America Artificial Blood Cells Market Size by Application
6.2.1 North America Artificial Blood Cells Sales by Application (2017-2028)
6.2.2 North America Artificial Blood Cells Revenue by Application (2017-2028)
6.3 North America Artificial Blood Cells Market Size by Country
6.3.1 North America Artificial Blood Cells Sales by Country (2017-2028)
6.3.2 North America Artificial Blood Cells Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Artificial Blood Cells Market Size by Source
7.1.1 Europe Artificial Blood Cells Sales by Source (2017-2028)
7.1.2 Europe Artificial Blood Cells Revenue by Source (2017-2028)
7.2 Europe Artificial Blood Cells Market Size by Application
7.2.1 Europe Artificial Blood Cells Sales by Application (2017-2028)
7.2.2 Europe Artificial Blood Cells Revenue by Application (2017-2028)
7.3 Europe Artificial Blood Cells Market Size by Country
7.3.1 Europe Artificial Blood Cells Sales by Country (2017-2028)
7.3.2 Europe Artificial Blood Cells Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Artificial Blood Cells Market Size by Source
8.1.1 Asia Pacific Artificial Blood Cells Sales by Source (2017-2028)
8.1.2 Asia Pacific Artificial Blood Cells Revenue by Source (2017-2028)
8.2 Asia Pacific Artificial Blood Cells Market Size by Application
8.2.1 Asia Pacific Artificial Blood Cells Sales by Application (2017-2028)
8.2.2 Asia Pacific Artificial Blood Cells Revenue by Application (2017-2028)
8.3 Asia Pacific Artificial Blood Cells Market Size by Region
8.3.1 Asia Pacific Artificial Blood Cells Sales by Region (2017-2028)
8.3.2 Asia Pacific Artificial Blood Cells Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Artificial Blood Cells Market Size by Source
9.1.1 Latin America Artificial Blood Cells Sales by Source (2017-2028)
9.1.2 Latin America Artificial Blood Cells Revenue by Source (2017-2028)
9.2 Latin America Artificial Blood Cells Market Size by Application
9.2.1 Latin America Artificial Blood Cells Sales by Application (2017-2028)
9.2.2 Latin America Artificial Blood Cells Revenue by Application (2017-2028)
9.3 Latin America Artificial Blood Cells Market Size by Country
9.3.1 Latin America Artificial Blood Cells Sales by Country (2017-2028)
9.3.2 Latin America Artificial Blood Cells Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Artificial Blood Cells Market Size by Source
10.1.1 Middle East and Africa Artificial Blood Cells Sales by Source (2017-2028)
10.1.2 Middle East and Africa Artificial Blood Cells Revenue by Source (2017-2028)
10.2 Middle East and Africa Artificial Blood Cells Market Size by Application
10.2.1 Middle East and Africa Artificial Blood Cells Sales by Application (2017-2028)
10.2.2 Middle East and Africa Artificial Blood Cells Revenue by Application (2017-2028)
10.3 Middle East and Africa Artificial Blood Cells Market Size by Country
10.3.1 Middle East and Africa Artificial Blood Cells Sales by Country (2017-2028)
10.3.2 Middle East and Africa Artificial Blood Cells Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Dextro-Sang Corporation
11.1.1 Dextro-Sang Corporation Corporation Information
11.1.2 Dextro-Sang Corporation Overview
11.1.3 Dextro-Sang Corporation Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Dextro-Sang Corporation Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Dextro-Sang Corporation Recent Developments
11.2 BioPure Corporation
11.2.1 BioPure Corporation Corporation Information
11.2.2 BioPure Corporation Overview
11.2.3 BioPure Corporation Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 BioPure Corporation Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 BioPure Corporation Recent Developments
11.3 Sangart
11.3.1 Sangart Corporation Information
11.3.2 Sangart Overview
11.3.3 Sangart Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sangart Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sangart Recent Developments
11.4 Northfield Laboratories
11.4.1 Northfield Laboratories Corporation Information
11.4.2 Northfield Laboratories Overview
11.4.3 Northfield Laboratories Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Northfield Laboratories Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Northfield Laboratories Recent Developments
11.5 Baxter International
11.5.1 Baxter International Corporation Information
11.5.2 Baxter International Overview
11.5.3 Baxter International Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Baxter International Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Baxter International Recent Developments
11.6 Dentritech
11.6.1 Dentritech Corporation Information
11.6.2 Dentritech Overview
11.6.3 Dentritech Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Dentritech Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Dentritech Recent Developments
11.7 FluorO2 Therapeutics
11.7.1 FluorO2 Therapeutics Corporation Information
11.7.2 FluorO2 Therapeutics Overview
11.7.3 FluorO2 Therapeutics Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 FluorO2 Therapeutics Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 FluorO2 Therapeutics Recent Developments
11.8 Nuvox Pharma
11.8.1 Nuvox Pharma Corporation Information
11.8.2 Nuvox Pharma Overview
11.8.3 Nuvox Pharma Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Nuvox Pharma Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Nuvox Pharma Recent Developments
11.9 Alpha Therapeutic Corporation
11.9.1 Alpha Therapeutic Corporation Corporation Information
11.9.2 Alpha Therapeutic Corporation Overview
11.9.3 Alpha Therapeutic Corporation Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Alpha Therapeutic Corporation Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Alpha Therapeutic Corporation Recent Developments
11.10 HemoBioTech
11.10.1 HemoBioTech Corporation Information
11.10.2 HemoBioTech Overview
11.10.3 HemoBioTech Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 HemoBioTech Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 HemoBioTech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Artificial Blood Cells Industry Chain Analysis
12.2 Artificial Blood Cells Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Artificial Blood Cells Production Mode & Process
12.4 Artificial Blood Cells Sales and Marketing
12.4.1 Artificial Blood Cells Sales Channels
12.4.2 Artificial Blood Cells Distributors
12.5 Artificial Blood Cells Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Artificial Blood Cells Industry Trends
13.2 Artificial Blood Cells Market Drivers
13.3 Artificial Blood Cells Market Challenges
13.4 Artificial Blood Cells Market Restraints
14 Key Findings in The Global Artificial Blood Cells Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Artificial Blood Cells Market Size Growth Rate by Source, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Animal Hemoglobin
Table 3. Major Manufacturers of Human Hemoglobin
Table 4. Major Manufacturers of Stem Cell
Table 5. Major Manufacturers of Others
Table 6. Global Artificial Blood Cells Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Artificial Blood Cells Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Artificial Blood Cells Sales by Region (2017-2022) & (K Units)
Table 9. Global Artificial Blood Cells Sales Market Share by Region (2017-2022)
Table 10. Global Artificial Blood Cells Sales by Region (2023-2028) & (K Units)
Table 11. Global Artificial Blood Cells Sales Market Share by Region (2023-2028)
Table 12. Global Artificial Blood Cells Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Artificial Blood Cells Revenue Market Share by Region (2017-2022)
Table 14. Global Artificial Blood Cells Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Artificial Blood Cells Revenue Market Share by Region (2023-2028)
Table 16. Global Artificial Blood Cells Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Artificial Blood Cells Sales Share by Manufacturers (2017-2022)
Table 18. Global Artificial Blood Cells Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Artificial Blood Cells Revenue Share by Manufacturers (2017-2022)
Table 20. Artificial Blood Cells Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Artificial Blood Cells Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Artificial Blood Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood Cells as of 2021)
Table 23. Artificial Blood Cells Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Artificial Blood Cells Product Offered
Table 25. Date of Manufacturers Enter into Artificial Blood Cells Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Artificial Blood Cells Sales by Source (2017-2022) & (K Units)
Table 28. Global Artificial Blood Cells Sales by Source (2023-2028) & (K Units)
Table 29. Global Artificial Blood Cells Sales Share by Source (2017-2022)
Table 30. Global Artificial Blood Cells Sales Share by Source (2023-2028)
Table 31. Global Artificial Blood Cells Revenue by Source (2017-2022) & (US$ Million)
Table 32. Global Artificial Blood Cells Revenue by Source (2023-2028) & (US$ Million)
Table 33. Global Artificial Blood Cells Revenue Share by Source (2017-2022)
Table 34. Global Artificial Blood Cells Revenue Share by Source (2023-2028)
Table 35. Artificial Blood Cells Price by Source (2017-2022) & (US$/Unit)
Table 36. Global Artificial Blood Cells Price Forecast by Source (2023-2028) & (US$/Unit)
Table 37. Global Artificial Blood Cells Sales by Application (2017-2022) & (K Units)
Table 38. Global Artificial Blood Cells Sales by Application (2023-2028) & (K Units)
Table 39. Global Artificial Blood Cells Sales Share by Application (2017-2022)
Table 40. Global Artificial Blood Cells Sales Share by Application (2023-2028)
Table 41. Global Artificial Blood Cells Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Artificial Blood Cells Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Artificial Blood Cells Revenue Share by Application (2017-2022)
Table 44. Global Artificial Blood Cells Revenue Share by Application (2023-2028)
Table 45. Artificial Blood Cells Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Artificial Blood Cells Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Artificial Blood Cells Sales by Source (2017-2022) & (K Units)
Table 48. North America Artificial Blood Cells Sales by Source (2023-2028) & (K Units)
Table 49. North America Artificial Blood Cells Revenue by Source (2017-2022) & (US$ Million)
Table 50. North America Artificial Blood Cells Revenue by Source (2023-2028) & (US$ Million)
Table 51. North America Artificial Blood Cells Sales by Application (2017-2022) & (K Units)
Table 52. North America Artificial Blood Cells Sales by Application (2023-2028) & (K Units)
Table 53. North America Artificial Blood Cells Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Artificial Blood Cells Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Artificial Blood Cells Sales by Country (2017-2022) & (K Units)
Table 56. North America Artificial Blood Cells Sales by Country (2023-2028) & (K Units)
Table 57. North America Artificial Blood Cells Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Artificial Blood Cells Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Artificial Blood Cells Sales by Source (2017-2022) & (K Units)
Table 60. Europe Artificial Blood Cells Sales by Source (2023-2028) & (K Units)
Table 61. Europe Artificial Blood Cells Revenue by Source (2017-2022) & (US$ Million)
Table 62. Europe Artificial Blood Cells Revenue by Source (2023-2028) & (US$ Million)
Table 63. Europe Artificial Blood Cells Sales by Application (2017-2022) & (K Units)
Table 64. Europe Artificial Blood Cells Sales by Application (2023-2028) & (K Units)
Table 65. Europe Artificial Blood Cells Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Artificial Blood Cells Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Artificial Blood Cells Sales by Country (2017-2022) & (K Units)
Table 68. Europe Artificial Blood Cells Sales by Country (2023-2028) & (K Units)
Table 69. Europe Artificial Blood Cells Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Artificial Blood Cells Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Artificial Blood Cells Sales by Source (2017-2022) & (K Units)
Table 72. Asia Pacific Artificial Blood Cells Sales by Source (2023-2028) & (K Units)
Table 73. Asia Pacific Artificial Blood Cells Revenue by Source (2017-2022) & (US$ Million)
Table 74. Asia Pacific Artificial Blood Cells Revenue by Source (2023-2028) & (US$ Million)
Table 75. Asia Pacific Artificial Blood Cells Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Artificial Blood Cells Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Artificial Blood Cells Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Artificial Blood Cells Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Artificial Blood Cells Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Artificial Blood Cells Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Artificial Blood Cells Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Artificial Blood Cells Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Artificial Blood Cells Sales by Source (2017-2022) & (K Units)
Table 84. Latin America Artificial Blood Cells Sales by Source (2023-2028) & (K Units)
Table 85. Latin America Artificial Blood Cells Revenue by Source (2017-2022) & (US$ Million)
Table 86. Latin America Artificial Blood Cells Revenue by Source (2023-2028) & (US$ Million)
Table 87. Latin America Artificial Blood Cells Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Artificial Blood Cells Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Artificial Blood Cells Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Artificial Blood Cells Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Artificial Blood Cells Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Artificial Blood Cells Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Artificial Blood Cells Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Artificial Blood Cells Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Artificial Blood Cells Sales by Source (2017-2022) & (K Units)
Table 96. Middle East and Africa Artificial Blood Cells Sales by Source (2023-2028) & (K Units)
Table 97. Middle East and Africa Artificial Blood Cells Revenue by Source (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Artificial Blood Cells Revenue by Source (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Artificial Blood Cells Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Artificial Blood Cells Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Artificial Blood Cells Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Artificial Blood Cells Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Artificial Blood Cells Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Artificial Blood Cells Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Artificial Blood Cells Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Artificial Blood Cells Revenue by Country (2023-2028) & (US$ Million)
Table 107. Dextro-Sang Corporation Corporation Information
Table 108. Dextro-Sang Corporation Description and Major Businesses
Table 109. Dextro-Sang Corporation Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Dextro-Sang Corporation Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Dextro-Sang Corporation Recent Developments
Table 112. BioPure Corporation Corporation Information
Table 113. BioPure Corporation Description and Major Businesses
Table 114. BioPure Corporation Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. BioPure Corporation Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. BioPure Corporation Recent Developments
Table 117. Sangart Corporation Information
Table 118. Sangart Description and Major Businesses
Table 119. Sangart Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Sangart Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sangart Recent Developments
Table 122. Northfield Laboratories Corporation Information
Table 123. Northfield Laboratories Description and Major Businesses
Table 124. Northfield Laboratories Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Northfield Laboratories Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Northfield Laboratories Recent Developments
Table 127. Baxter International Corporation Information
Table 128. Baxter International Description and Major Businesses
Table 129. Baxter International Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Baxter International Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Baxter International Recent Developments
Table 132. Dentritech Corporation Information
Table 133. Dentritech Description and Major Businesses
Table 134. Dentritech Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Dentritech Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Dentritech Recent Developments
Table 137. FluorO2 Therapeutics Corporation Information
Table 138. FluorO2 Therapeutics Description and Major Businesses
Table 139. FluorO2 Therapeutics Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. FluorO2 Therapeutics Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. FluorO2 Therapeutics Recent Developments
Table 142. Nuvox Pharma Corporation Information
Table 143. Nuvox Pharma Description and Major Businesses
Table 144. Nuvox Pharma Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Nuvox Pharma Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Nuvox Pharma Recent Developments
Table 147. Alpha Therapeutic Corporation Corporation Information
Table 148. Alpha Therapeutic Corporation Description and Major Businesses
Table 149. Alpha Therapeutic Corporation Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Alpha Therapeutic Corporation Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Alpha Therapeutic Corporation Recent Developments
Table 152. HemoBioTech Corporation Information
Table 153. HemoBioTech Description and Major Businesses
Table 154. HemoBioTech Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. HemoBioTech Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. HemoBioTech Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Artificial Blood Cells Distributors List
Table 160. Artificial Blood Cells Customers List
Table 161. Artificial Blood Cells Market Trends
Table 162. Artificial Blood Cells Market Drivers
Table 163. Artificial Blood Cells Market Challenges
Table 164. Artificial Blood Cells Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Artificial Blood Cells Product Picture
Figure 3. Global Artificial Blood Cells Market Share by Source in 2021 & 2028
Figure 3. Animal Hemoglobin Product Picture
Figure 4. Human Hemoglobin Product Picture
Figure 5. Stem Cell Product Picture
Figure 6. Others Product Picture
Figure 7. Global Artificial Blood Cells Market Share by Application in 2021 & 2028
Figure 8. Cardiovascular Diseases
Figure 9. Anemia
Figure 10. Organ Transplant
Figure 11. Others
Figure 12. Artificial Blood Cells Report Years Considered
Figure 13. Global Artificial Blood Cells Sales 2017-2028 (K Units)
Figure 14. Global Artificial Blood Cells Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Artificial Blood Cells Revenue 2017-2028 (US$ Million)
Figure 16. Global Artificial Blood Cells Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Artificial Blood Cells Sales Market Share by Region (2017-2022)
Figure 18. Global Artificial Blood Cells Sales Market Share by Region (2023-2028)
Figure 19. North America Artificial Blood Cells Sales YoY (2017-2028) & (K Units)
Figure 20. North America Artificial Blood Cells Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Artificial Blood Cells Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Artificial Blood Cells Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Artificial Blood Cells Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Artificial Blood Cells Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Artificial Blood Cells Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Artificial Blood Cells Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Artificial Blood Cells Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Artificial Blood Cells Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Artificial Blood Cells Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Artificial Blood Cells in the World: Market Share by Artificial Blood Cells Revenue in 2021
Figure 31. Global Artificial Blood Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Artificial Blood Cells Sales Market Share by Source (2017-2028)
Figure 33. Global Artificial Blood Cells Revenue Market Share by Source (2017-2028)
Figure 34. Global Artificial Blood Cells Sales Market Share by Application (2017-2028)
Figure 35. Global Artificial Blood Cells Revenue Market Share by Application (2017-2028)
Figure 36. North America Artificial Blood Cells Sales Market Share by Source (2017-2028)
Figure 37. North America Artificial Blood Cells Revenue Market Share by Source (2017-2028)
Figure 38. North America Artificial Blood Cells Sales Market Share by Application (2017-2028)
Figure 39. North America Artificial Blood Cells Revenue Market Share by Application (2017-2028)
Figure 40. North America Artificial Blood Cells Sales Share by Country (2017-2028)
Figure 41. North America Artificial Blood Cells Revenue Share by Country (2017-2028)
Figure 42. United States Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Artificial Blood Cells Sales Market Share by Source (2017-2028)
Figure 45. Europe Artificial Blood Cells Revenue Market Share by Source (2017-2028)
Figure 46. Europe Artificial Blood Cells Sales Market Share by Application (2017-2028)
Figure 47. Europe Artificial Blood Cells Revenue Market Share by Application (2017-2028)
Figure 48. Europe Artificial Blood Cells Sales Share by Country (2017-2028)
Figure 49. Europe Artificial Blood Cells Revenue Share by Country (2017-2028)
Figure 50. Germany Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 51. France Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Artificial Blood Cells Sales Market Share by Source (2017-2028)
Figure 56. Asia Pacific Artificial Blood Cells Revenue Market Share by Source (2017-2028)
Figure 57. Asia Pacific Artificial Blood Cells Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Artificial Blood Cells Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Artificial Blood Cells Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Artificial Blood Cells Revenue Share by Region (2017-2028)
Figure 61. China Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 64. India Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 66. China Taiwan Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Artificial Blood Cells Sales Market Share by Source (2017-2028)
Figure 71. Latin America Artificial Blood Cells Revenue Market Share by Source (2017-2028)
Figure 72. Latin America Artificial Blood Cells Sales Market Share by Application (2017-2028)
Figure 73. Latin America Artificial Blood Cells Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Artificial Blood Cells Sales Share by Country (2017-2028)
Figure 75. Latin America Artificial Blood Cells Revenue Share by Country (2017-2028)
Figure 76. Mexico Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Artificial Blood Cells Sales Market Share by Source (2017-2028)
Figure 80. Middle East and Africa Artificial Blood Cells Revenue Market Share by Source (2017-2028)
Figure 81. Middle East and Africa Artificial Blood Cells Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Artificial Blood Cells Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Artificial Blood Cells Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Artificial Blood Cells Revenue Share by Country (2017-2028)
Figure 85. Turkey Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Artificial Blood Cells Revenue (2017-2028) & (US$ Million)
Figure 88. Artificial Blood Cells Value Chain
Figure 89. Artificial Blood Cells Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed

---